WEDNESDAY, DECEMBER 17, 2025 1:43:45 PM

(A)+ (A) (A)- Skip to main content

corporate consultancy

empowered investor

download

career

Quotes

News

NAV

Daily Market Tracker

Market Analysis

Stock Screener


Balance Sheet	Markets > Corporate Information > Balance Sheet


Amkay Products Ltd	Industry: Healthcare

BSE Code	ISIN Demat	Book Value (R)	NSE Symbol	Div Yield %	Market Cap (Rs.Cr)	P/E (TTM)	EPS (TTM)	Face Value (R)
544169	INE0QSB01016	27.802843	Not Listed	0	65.00	25.81	2.91	10

Particulars	Mar 2025 (Rs.Cr)	Mar 2024 (Rs.Cr)	Mar 2023 (Rs.Cr)	Mar 2022 (Rs.Cr)	Mar 2021 (Rs.Cr)	Mar 2020 (Rs.Cr)
SOURCES OF FUNDS :
Share Capital	8.66	6.36	0.28	0.28	0.28	0.28
Reserves Total	15.41	3.64	7.10	5.93	5.67	2.42
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	24.07	10.00	7.38	6.21	5.95	2.70
Secured Loans	1.01	1.24	1.14	0.02	-0.88	0.45
Unsecured Loans	1.63	4.23	3.56	4.31	1.30	1.17
Total Debt	2.64	5.47	4.70	4.33	0.42	1.62
Other Liabilities	0.08	0.07	0.05	0.05	0.00	0.00
Total Liabilities	26.79	15.54	12.13	10.59	6.37	4.32
APPLICATION OF FUNDS :
Gross Block	11.22	8.90	8.17	8.16	6.72	5.56
Less : Accumulated Depreciation	7.09	6.32	5.76	4.25	4.17	3.66
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	4.13	2.58	2.41	3.91	2.55	1.90
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.12	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	6.85	2.57	3.62	2.79	0.40	0.00
Current Assets, Loans & Advances
Inventories	8.12	5.61	2.61	1.98	0.29	0.21
Sundry Debtors	6.01	3.99	3.70	3.63	4.50	2.26
Cash and Bank Balance	1.54	0.11	0.05	0.20	0.03	0.17
Loans and Advances	1.49	1.78	2.03	2.57	1.94	0.86
Total Current Assets	17.16	11.49	8.39	8.39	6.76	3.50
Less : Current Liabilities and Provisions
Current Liabilities	3.09	2.40	2.76	4.82	6.42	2.24
Provisions	0.01	0.01	0.10	0.40	1.27	0.31
Total Current Liabilities & Provisions	3.10	2.41	2.86	5.21	7.69	2.55
Net Current Assets	14.06	9.07	5.53	3.17	-0.93	0.95
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.26	0.21	0.28	0.24	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.26	0.21	0.28	0.24	0.00	0.00
Other Assets	1.36	1.10	0.29	0.47	4.35	1.47
Total Assets	26.78	15.53	12.12	10.58	6.37	4.32
Contingent Liabilities	0.00	0.00	0.43	0.14	0.00	0.00

Useful Links

NSE

BSE

SEBI

CDSL

NSDL

RBI

FMC

AMFI

Stock Watch

Derivatives on NSE

MOF

NISM

MCA

In case of any grievances please write to: investorgrievance@questgroup.in

Quest Securities Limited: Sebi Reg No. INZ000271639 DP : IN-DP-CDSL-167-2015 CIN:U93030DL2009PLC190452

Quest Global Commodities (P) Ltd: Sebi Reg No . INZ000035039 CIN :U74999DL2004PTC128895

Attention Investors :
Prevent Unauthorised Transactions in your Trading / Demat account -->Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL/CDSL on the same day……Issued in the interest of investors. KYC is one time exercise while dealing in securities markets –once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Prevent Unauthorized transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.......... Issued in the interest of investors.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.

You can also lodge your grievances with SEBI at : https://scores.sebi.gov.in/

Copyright © 2013 Quest Securities Limited.

Designed, Developed and Powered by CMOTS Infotech (ISO 9001:2015 certified)